Giorgio Chirivi
Direktor/Vorstandsmitglied bei Axxam SpA
Ursprung des Netzwerks ersten Grades von Giorgio Chirivi
Einheit | Art der Einheit | Industrie | |
---|---|---|---|
Axxam SpA
Axxam SpA Miscellaneous Commercial ServicesCommercial Services Axxam SpA provides pharmaceuticals services. The firm specializes in molecular biology, electrophysiology, cellular and biochemical systems. The company was founded by Stefan Lohmer and Alessandro Sidoli in November 2001 and is headquartered in Bresso, Italy.
6
| Holding Company | Miscellaneous Commercial Services | 6 |
Biocell Center Corp.
Biocell Center Corp. Miscellaneous Commercial ServicesCommercial Services Part of Biocell Center SpA, Biocell Center Corp. is an American company that carries out research and development activities on fetal stem cells from amniotic fluid and chorionic villi. The company is located in the US. The company is the world leader in fetal stem cell banking, offering cryopreservation services. In collaboration with their partner, Bin Project, they have created a network of companies focused on the development of a biocompatible scaffold for bone regeneration.
1
| Subsidiary | Miscellaneous Commercial Services | 1 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Giorgio Chirivi
Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
---|---|---|---|
MOLMED S.P.A. | Pharmaceuticals: Major | Chief Operating Officer | |
SILENCE THERAPEUTICS PLC | Miscellaneous Commercial Services | Corporate Officer/Principal | |
Imperial College London | College/University | Doctorate Degree | |
University of Cambridge | College/University | Graduate Degree | |
University of Bocconi | College/University | Graduate Degree | |
University of Pavia | College/University | Undergraduate Degree | |
University of Milan | College/University | Undergraduate Degree | |
The University of Exeter | College/University | Doctorate Degree | |
Externautics SpA
Externautics SpA BiotechnologyHealth Technology Externautics SpA provides biotechnology research and development services. The firms designs and manages platforms that identify and develop novel diagnostic and therapeutic markers for oncology applications. Its technology approach is based on the screening of libraries of polyclonal antibodies and recombinant proteins, generated from the corresponding human gene library of the poorly known membrane and secreted proteins. It focuses on the identification of membrane-exposed or serum circulating proteins whose presence associate to the frequent types of human tumors. The company was founded by Guido Grandi in 2007 and is headquartered in Siena, Italy. | Biotechnology | Director/Board Member | |
Primm SRL
Primm SRL BiotechnologyHealth Technology Primm SRL engages in the manufacturing, marketing and sale of biotech services. It offers poly and monoclonal antibodies, peptides, DNA synthesis, DNA sequencing, protein analysis, gene cloning, recombinant protein and pharmacological and toxicological services. The firm provides research and development activities which focuses on the design, synthesis, and pharmaceutical development of bioactive peptides for therapeutical applications. The company was founded by Sidoli Alessandro in 1990 and is based in Milan, Italy. | Biotechnology | Founder | |
Fondazione Toscana Life Sciences
Fondazione Toscana Life Sciences Miscellaneous Commercial ServicesCommercial Services Fondazione Toscana Life Sciences is a non-profit organization founded by and composed of public and private institutions. These institutions encompass banks, universities, provincial, municipal and educational entities. The organization was founded in 2004 and is headquartered in Sienna, Italy. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
Zambon SpA
Zambon SpA Pharmaceuticals: MajorHealth Technology Zambon SpA is engaged in manufacturing pharmaceutical products. It offers anauran, anaurette, asacol, codex, fluimucil, and giason. The company is headquartered in Bresso, Italy. | Pharmaceuticals: Major | Chief Executive Officer | |
Università degli Studi di Napoli Federico II | College/University | Undergraduate Degree | |
Federazione Nazionale dell'Industria Chimica | Director/Board Member | ||
Biocell Center SpA
Biocell Center SpA BiotechnologyHealth Technology Biocell Center SpA develops cryopreservation service for stem cells from amniotic fluid and chorionic villi. It specializes in the study and research of amniotic stem cells, discovering a method for extracting and preserving such stem cells. The firm also operates as an infertility center and provides services in andrology, gynaecology, obstetrics, and post-natal services, and neonatology. The company was founded by Marco Reguzzoni and is headquartered in Busto Arsizio, Italy. | Biotechnology | Corporate Officer/Principal | |
University of Kent | College/University | Undergraduate Degree | |
XBRANE BIOPHARMA AB | Pharmaceuticals: Major | Director/Board Member | |
University of Insubria | College/University | Undergraduate Degree | |
Acousia Therapeutics GmbH
Acousia Therapeutics GmbH BiotechnologyHealth Technology Acousia Therapeutics GmbH identifies small molecules for treatment of hearing loss. The firm develops drugs for local application, which will protect hearing function or restore hearing in patients who have lost their hearing ability due to various reasons. It also develops small molecule compounds that trigger regeneration of sensory hair cells and therefore allow casual treatment of sensorineural hearing loss in patients who already lost their hair cells years ago. The company was founded by Hubert Löwenheim and Karl-Heinz Wiesmüller in 2012 and is headquartered in Tübingen, Germany. | Biotechnology | Director/Board Member | |
eGenesis, Inc.
eGenesis, Inc. Miscellaneous Commercial ServicesCommercial Services eGenesis, Inc. operates research platform to deliver human transplantable cells, tissues, and organs grown in pigs. It uses gene editing technology such as CRISPR to directly address the key virology and immunology hurdles that have impeded xenotransplantation. The company was founded by George M. Church, Yang Luhan, Prashant Mali, Geoff Mackay and Guell Marc in 2015 and is headquartered in Cambridge, MA. | Miscellaneous Commercial Services | Director/Board Member | |
Italian Association of Business Angels | Founder | ||
AZITRA, INC. | Pharmaceuticals: Major | Director/Board Member | |
IMAX Discovery GmbH
IMAX Discovery GmbH Food: Specialty/CandyConsumer Non-Durables Part of IMAX Corp., IMAX Discovery GmbH develops novel and natural flavor compounds for the food and beverage industry. The company is based in Dortmund, Germany. The CEO of the German company is Alessandro Sidoli. | Food: Specialty/Candy | Chief Executive Officer | |
GRO Biosciences, Inc.
GRO Biosciences, Inc. Pharmaceuticals: MajorHealth Technology GRO Biosciences, Inc. develops genomically recoded organisms to express therapeutic proteins. The company was founded by George McDonald Church, Andrew D. Ellington, Daniel J. Mandell, Christopher J. Gregg, P. Benjamin Stranges, Marc J. Lajoie, and Ross Thyer in 2016 and is headquartered in Cambridge, MA. | Pharmaceuticals: Major | Director/Board Member | |
Istituto Sieroterapico Milanese | Corporate Officer/Principal | ||
Khloris Biosciences, Inc.
Khloris Biosciences, Inc. Miscellaneous Commercial ServicesCommercial Services Khloris Biosciences, Inc. operates as biotechnology company. The firm offers drug discovery, vaccine and cell therapies for treatment and prevention of cancer. The company was founded by Lynne A. Bui and Joseph C. Wu in June 2017 and is headquartered in Mountain View, CA. | Miscellaneous Commercial Services | Director/Board Member | |
Leaps by Bayer
Leaps by Bayer Investment ManagersFinance Leaps by Bayer is venture investment unit of Bayer AG (Xetra: BAYN) founded in 2015. The firm is headquartered in Leverkusen, Germany. | Investment Managers | Director/Board Member | |
PYXIS ONCOLOGY, INC. | Pharmaceuticals: Major | Director/Board Member | |
Immunitas Therapeutics, Inc.
Immunitas Therapeutics, Inc. BiotechnologyHealth Technology Immunitas Therapeutics, Inc. provides cancer therapeutics services. The company was founded by Lea Hachigian, Kai Wucherpfennig, K. Dane Wittrup and Mario Suv? and is headquartered in Cambridge, MA. | Biotechnology | Director/Board Member | |
Kojin Therapeutics, Inc.
Kojin Therapeutics, Inc. BiotechnologyHealth Technology Kojin Therapeutics, Inc. operates as a small-molecule therapeutics company. It focuses on translating deep biological insight into the plasticity of human cell states to develop therapeutics for cancer, fibrosis, ischemia and immune modulation. The company was founded by Benjamin Cravatt, Stephanie K. Dougan and Stuart L.Schreiber and is headquartered in the United States. | Biotechnology | Director/Board Member | |
Vesigen, Inc.
Vesigen, Inc. BiotechnologyHealth Technology Vesigen, Inc. develops groundbreaking therapeutic products directed to intracellular targets using a scalable and extracellular vesicle delivery technology. The company is headquartered in Cambridge, MA. | Biotechnology | Director/Board Member | |
Mozart Therapeutics, Inc.
Mozart Therapeutics, Inc. BiotechnologyHealth Technology Mozart Therapeutics, Inc. is a company focused on developing first-in-class disease-modifying therapies for autoimmune and inflammatory diseases, with a therapeutic focus on autoimmune mediated gastro-intestinal disorders. The company is based in Seattle, WA. The company utilizes a novel approach to restoring immune system function by targeting the CD8 T regulatory network. Mozart Therapeutics is advancing a pipeline of first-in-class ‘CD8 Treg modulators’ designed to restore durable immune balance. The CEO of the company is Katie Fanning. | Biotechnology | Director/Board Member | |
Leaps By Bayer /US/ | Investment Managers | Private Equity Investor | |
Paratus Sciences Corp.
Paratus Sciences Corp. BiotechnologyHealth Technology Paratus Sciences Corp. is an American company that focuses on unlocking the secrets of bat biology. The company's main goal is to elucidate novel insights and identify new therapeutic targets. The company was founded by Thomas Zwaka, Richard Young, Paul Matsudaira. The CEO is Amir H. Nashat. | Biotechnology | Director/Board Member | |
Bausch & Lomb-IOM SpA
Bausch & Lomb-IOM SpA Medical DistributorsDistribution Services Bausch & Lomb-IOM SpA engages in the distribution and wholesale of contact lenses and accessories. The company was founded in 1972 and is headquartered in Vimodrone, Italy. | Medical Distributors | Chief Administrative Officer |
Statistik
International
Italien | 17 |
Vereinigte Staaten | 12 |
Vereinigtes Königreich | 6 |
Deutschland | 4 |
Schweden | 2 |
Sektoral
Health Technology | 17 |
Consumer Services | 10 |
Commercial Services | 5 |
Finance | 3 |
Consumer Non-Durables | 2 |
Operativ
Director/Board Member | 20 |
Corporate Officer/Principal | 8 |
Undergraduate Degree | 5 |
Chief Executive Officer | 4 |
Founder | 4 |
Am stärksten vernetzte Beziehungen
- Börse
- Insiders
- Giorgio Chirivi
- Unternehmensverbindungen